Your browser doesn't support javascript.
loading
Corrigendum: Machine learning prediction model for post- hepatectomy liver failure in hepatocellular carcinoma: a multicenter study.
Wang, Jitao; Zheng, Tianlei; Liao, Yong; Geng, Shi; Li, Jinlong; Zhang, Zhanguo; Shang, Dong; Liu, Chengyu; Yu, Peng; Huang, Yifei; Liu, Chuan; Liu, Yanna; Liu, Shanghao; Wang, Mingguang; Liu, Dengxiang; Miao, Hongrui; Li, Shuang; Zhang, Biao; Huang, Anliang; Zhang, Yewei; Qi, Xiaolong; Chen, Shubo.
Afiliación
  • Wang J; Xingtai Key Laboratory of Precision Medicine for Liver Cirrhosis and Portal Hypertension, Xingtai People's Hospital, Xingtai, Hebei, China.
  • Zheng T; Center of Portal Hypertension, Department of Radiology, Zhongda Hospital, Medical School, Southeast University, Nanjing, Jiangsu, China.
  • Liao Y; Artificial Intelligence Unit, Department of Medical Equipment Management, Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China.
  • Geng S; School of Information and Control Engineering, China University of Mining and Technology Xuzhou, Jiangsu, China.
  • Li J; Xingtai Key Laboratory of Precision Medicine for Liver Cirrhosis and Portal Hypertension, Xingtai People's Hospital, Xingtai, Hebei, China.
  • Zhang Z; Artificial Intelligence Unit, Department of Medical Equipment Management, Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China.
  • Shang D; Xingtai Key Laboratory of Precision Medicine for Liver Cirrhosis and Portal Hypertension, Xingtai People's Hospital, Xingtai, Hebei, China.
  • Liu C; Department of Hepatobiliary Surgery, Tongji Hospital Affiliated to Huazhong University of Science and Technology, Wuhan, Hubei, China.
  • Yu P; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China.
  • Huang Y; Xingtai Key Laboratory of Precision Medicine for Liver Cirrhosis and Portal Hypertension, Xingtai People's Hospital, Xingtai, Hebei, China.
  • Liu C; Department of Hepatobiliary Surgery, Fifth Medical Center of PLA General Hospital, Beijing, China.
  • Liu Y; Institute of Portal Hypertension, The First Hospital of Lanzhou University, Lanzhou, China.
  • Liu S; Center of Portal Hypertension, Department of Radiology, Zhongda Hospital, Medical School, Southeast University, Nanjing, Jiangsu, China.
  • Wang M; Department of Microbiology and Infectious Disease Center, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China.
  • Liu D; Center of Portal Hypertension, Department of Radiology, Zhongda Hospital, Medical School, Southeast University, Nanjing, Jiangsu, China.
  • Miao H; Center of Portal Hypertension, Department of Radiology, Zhongda Hospital, Medical School, Southeast University, Nanjing, Jiangsu, China.
  • Li S; Center of Portal Hypertension, Department of Radiology, Zhongda Hospital, Medical School, Southeast University, Nanjing, Jiangsu, China.
  • Zhang B; Department of Hepatobiliary Surgery, Tongji Hospital Affiliated to Huazhong University of Science and Technology, Wuhan, Hubei, China.
  • Huang A; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China.
  • Zhang Y; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China.
  • Qi X; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China.
  • Chen S; Department of Hepatobiliary Surgery, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
Front Oncol ; 13: 1278295, 2023.
Article en En | MEDLINE | ID: mdl-37719010
[This corrects the article DOI: 10.3389/fonc.2022.986867.].
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Oncol Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Oncol Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza